-
Post-Vaccine Symptomatic Return to Work
Key Points: In today’s Recommendations for Industry, we discuss post-vaccine symptomatic return to work for those receiving the vaccine and not feeling well. In addition, we discuss the US Risk Matrix. [Read More] Johnson and Johnson’s EUA documentation submitted to the FDA has been released. We will discuss this more on Friday. In the huge…
-
COVID-19 Vaccine Progress and Education
Key Points: In today’s Recommendations for Industry, we discuss the current status of vaccinations across the U.S. and the importance of education. Read more below. The New York Times discusses vaccine alarmism that addresses the conflicting messages that “may be dissuading people from getting vaccinated.” According to NYT polls, “nearly half of Americans would refuse…
-
Layered Masks & COVID-19 Vaccination Update
Key Points: In today’s Recommendations for Industry, we discuss new recommendations from CDC for masks and quarantining vaccinated persons. Read more below. The CDC has declared that individuals who have received the full course of a COVID-19 vaccine do not need to quarantine for 10 – 14 days post-exposure to a COVID-infected individual, as long…
-
COVID-19 Vaccinations & Protective Behaviors
Key Points: In today’s Recommendations for Industry, we discuss the importance of businesses staying updated on vaccine availability for employees and not let up on any of the basic controls and protective behaviors [Read More]. The FDA has scheduled its meeting to review Johnson & Johnson’s EUA for COVID-19 vaccine (Vaccines and Related Biological Products…
-
COVID-19 Post-Vaccination Symptom Protocols
Key Points: In today’s Recommendations for Industry, we discuss what to do if a person exhibits symptoms after receiving the COVID-19 vaccine. Read More The Super Bowl is this Sunday. Please do not “go crazy”; to prevent a superspreading event and continue our decreasing trends of COVID-19, remind your workforce of the importance of practicing…